COMMUNIQUÉS West-GlobeNewswire

Genmab A/S Share Capital Reduction
17/04/2026
Company Announcement COPENHAGEN, Denmark; April 17, 2026 – Genmab A/S (Nasdaq: GMAB) At Genmab A/S’ Annual General Meeting on March 19, 2026, it was decided to reduce the Company’s share capital with nominally DKK 1,900 [...]
Yuhua Zhang, PhD, Named Chairholder of the Carolyn and Chuck Miller Endowed Chair for Vision Research
17/04/2026
PASADENA, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research institutions for nearly 80 years, named Yuhua Zhang, PhD, chairholder of the Carolyn and Chuck [...]
Dogecoin Cash, Inc. (OTCQB: DOGP) Announces Development Initiative for “Dogecoin Gold” Digital Asset Framework
17/04/2026
MESQUITE, NV, April 17, 2026 (GLOBE NEWSWIRE) -- Dogecoin Cash, Inc. (OTCQB: DOGP) (“DOGP” or the “Company”) today announced it is advancing the development of “Dogecoin Gold,” a proposed blockchain-based digital asset [...]
SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson
17/04/2026
EMJ Crypto Technologies (EMJX) Founder and CEO Mr. Jackson provides update on operational progress and timing of proposed merger between SRx Health Solutions and EMJX NORTH PALM BEACH, Fla., April 17, 2026 (GLOBE [...]
Global Widget Celebrates 10 Years as a Leader in Premium Gummy Manufacturing
17/04/2026
Global Widget, LLC, a leading U.S.-based contract manufacturer specializing in gummy supplements, is celebrating its 10-year anniversary after a decade of rapid growth and operational expansion. Tampa, Florida, April 17 [...]
Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
17/04/2026
SOUTH SAN FRANCISCO, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral vaccines based on its proprietary [...]
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
17/04/2026
Live event to be held on Thursday, April 23, at 2:00 p.m. ET Company focused on advancing launch strategy ahead of November 14 PDUFA target action date NEW HAVEN, Conn., April 17, 2026 (GLOBE NEWSWIRE) -- BioXcel [...]
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
17/04/2026
WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its new Repligen [...]
Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy
17/04/2026
Strong global consensus on measurement and role of ammonia in Hepatic Encephalopathy (HE) Phase 2a results of YAQ007 (oral OPA) show ammonia reduction Utility of rifaximin in HE defined more narrowly LONDON, April 17, [...]
Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight
17/04/2026
KUALA LUMPUR, Malaysia, April 17, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “ Company ” or “ Alps Group ”), the parent company of Alps Life Sciences Inc. (“ Alps Holdco ”), a biotechnology research and healthcare [...]
Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds
17/04/2026
In a 12‑week comparative study, Omada GLP‑1 Care Track members, on average, lost more weight and saw greater improvements in body composition than controls, pointing to increased value for employers and health plans. [...]
Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
17/04/2026
Company highlights global leadership in GMP ibogaine manufacturing and commitment to ethically sourced supply NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “ [...]
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
17/04/2026
– Updated presentation on Cogent’s potent pan-KRAS(ON) inhibitor, CGT1263, showcasing its selectivity profile which could lead to reduction in skin toxicity associated with multi-RAS inhibitors – Updated presentation on [...]
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
17/04/2026
INBS implements enhanced security architecture to protect test integrity and donor data, strengthening upcoming FDA 510(k) submission NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: [...]
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
17/04/2026
WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today [...]
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
17/04/2026
WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange [...]
Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting
17/04/2026
Oral presentation highlights additional data from PROGRESS Phase 2b study of pilavapadin supporting selection of 10mg as optimal dose for Phase 3 development in DPNP New data on spasticity further validates the broader [...]
Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
17/04/2026
Targets rare, high-burden genetic condition with no approved therapies; advances non-surgical treatment strategy for recurrent basal cell carcinoma PHILADELPHIA, April 17, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. ( [...]
Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors
17/04/2026
MELBOURNE, Australia and SAN FRANCISCO, April 17, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying [...]

Pages